Log in or create a free account to read this content
Gain free access to this article, as well as selected content from this journal and more on nature.com
or
References
Carneiro AM, Cook EH, Murphy DL, Blakely RD (2008). Interactions between integrin alphaIIbbeta3 and the serotonin transporter regulate serotonin transport and platelet aggregation in mice and humans. J Clin Invest 118: 1544–1552.
Cingolani LA, Thalhammer A, Yu LM, Catalano M, Ramos T, Colicos MA et al (2008). Activity-dependent regulation of synaptic AMPA receptor composition and abundance by beta3 integrins. Neuron 58: 749–762.
Denda S, Reichardt LF (2007). Studies on integrins in the nervous system. Methods Enzymol 426: 203–221.
Miller WH, Keenan RM, Willette RN, Lark MW (2000). Identification and in vivo efficacy of small-molecule antagonists of integrin alphavbeta3 (the vitronectin receptor). Drug Discov Today 5: 397–408.
Watson PM, Humphries MJ, Relton J, Rothwell NJ, Verkhratsky A, Gibson RM et al (2007). Integrin-binding RGD peptides induce rapid intracellular calcium increases and MAPK signaling in cortical neurons. Mol Cell Neurosci 34: 147–154.
Wiggins AT, Pacchioni AM, Kalivas PW (2009). Integrin expression is altered after acute and chronic cocaine. Neurosci Lett 450: 321–323.
Author information
Authors and Affiliations
Corresponding author
Additional information
DISCLOSURE
The author declares that except for income received from primary employer, no financial support or compensation has been received from any individual or corporate entity over the past 3 years for research or professional service, and there are no personal financial holdings that could be perceived as constituting a potential conflict of interest.
Rights and permissions
About this article
Cite this article
Carneiro, A. The emerging role of integrins in neuropsychiatric disorders. Neuropsychopharmacol 35, 338–339 (2010). https://doi.org/10.1038/npp.2009.134
Published:
Issue date:
DOI: https://doi.org/10.1038/npp.2009.134